Timo Minssen
Professor
JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
- Published
The interface between Big Data, IP and competition in the health and life sciences
Minssen, Timo, 2017.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
- Published
The problem with antibiotics
Darrow, J. & Minssen, Timo, May 2019, In: The Economist. 431, 9144, p. 20 1 p.Research output: Contribution to journal › Letter › Research
- Published
The revival of Phage Therapy to fight Antimicrobial Resistance (AMR) – Part III: What about patent protection and alternative incentives?
Minssen, Timo, 8 Aug 2014Research output: Other contribution › Net publication - Internet publication › Research
- Published
The revival of Phage Therapy to fight Antimicrobial Resistance – Part I: What are the legal implications?
Minssen, Timo, 4 Aug 2014Research output: Other contribution › Net publication - Internet publication › Research
- Published
The revival of Phage Therapy to fight Antimicrobial Resistance – Part II: What about patent protection and alternative incentives?
Minssen, Timo, 7 Aug 2014Research output: Other contribution › Net publication - Internet publication › Research
- Published
The ”opt out” and “opt in” provisions in the Unified Patent Court Agreement – Impact and strategies for European patent portfolios
Minssen, Timo & Lundqvist, B., 2014, In: N I R. 4, p. 340-357 18 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Towards Responsible Quantum Technology: Safeguarding, Engaging and Advancing Quantum R&D
Kop, M., Aboy, M., De Jong, E., Gasser, U., Minssen, Timo, Cohen, G., Brongersma, M. L., Quintel, T., Floridi, L. & Laflamme, R., 2024, In: The UC Law Science and Technology Journal (fmr. Hastings Science & Technology Law Journal). 15, 1, p. 63 - 94 31 p., 4.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
US COVID IP waiver U-turn will not fix the vaccines access crisis
Matthews, D. & Minssen, Timo, 17 Jun 2021, In: Financial Times (London, 1888).Research output: Contribution to journal › Contribution to newspaper - Feature article › Communication
- Published
US Patent Eligibility in the Wake of Bilski v. Kappos: Business as Usual in an Age of New Technologies?
Minssen, Timo & Schwartz, R., 2011, In: Biotechnology Law Report. 30, 1, p. 3 - 56 54 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Submitted
UTILITY MODELS IN DANISH LAW
Sommer, T., Minssen, Timo & Schovsbo, Jens Hemmingsen, 2024, (Submitted) Sub-Patent Innovation Rights: Utility Models, Petty Patents and Innovation Patents Around the World. Contreras, J. (ed.). Cambridge University PressResearch output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
ID: 16150437
Most downloads
-
4331
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2203
downloads
The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2080
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published